Reviving A Longsuffering Neuro Company: The Marinus Story

 
• By Jo Shorthouse

Marinus Pharmaceuticals’ CEO spoke candidly to In Vivo about breathing new life into ultra-rare epilepsy disorder drug ganaxolone.    

Phoenix flying high
Marinus' phoenix has now risen from the ashes • Source: Shutterstock

More from Leadership

More from In Vivo